The DOJ lawsuit alleges that CVS has, for more than a decade, knowingly filled sometimes-dubious prescriptions for controlled substances that lacked a legitimate medical purpose, or were not valid.

"Safety issues arise when one is dealing with medication and also being rushed to fulfill an order like McDonald's," one employee allegedly wrote. "CVS has concocted an assembly-line style of ...

CVS has been hit with at least three federal class actions, including two antitrust cases accusing CVS Caremark Corp ... conglomerate that also owns mail-order, specialty, and/or retail pharmacies ...

CVS is a PBM through its CVS Caremark business. The company's pharmacy and consumer-wellness segment represented 34% of total revenue of $95.4 billion in the latest quarter. And UnitedHealth's ...

A potential breakup of CVS Caremark may unlock value, but could also result in more leadership attrition in an already-troubled company. I don't think Q3 FY24 results provide any real hope for a ...

The three dominant companies — Express Scripts, CVS Caremark and Optum Rx — oversee prescriptions for more than 200 million people and are part of health care conglomerates that sit near the ...

Members of the House Judiciary Committee last week announced an investigation of CVS Caremark for potential practices that could limit patient access to innovative services provided by some ...

CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. Read More on CVS: CVS Health NewsMORE Related Stocks Indices Commodities ...

CVS has been hit with at least three federal class actions, including two antitrust cases accusing CVS Caremark Corp ... conglomerate that also owns mail-order, specialty, and/or retail pharmacies ...

House Republicans are investigating whether CVS Caremark, a leading pharmacy benefit manager, violated federal antitrust laws by allegedly blocking independent pharmacies from using cost-saving ...

House Republicans want to know whether pharmacy benefit manager (PBM) CVS Caremark violated federal antitrust laws by threatening independent pharmacies to keep them from using money-saving tools ...